Join the Victorian ASCERATAIN Study: Your participation matters

You are invited to contribute to the AtheroSclerotic Cardiovascular disEase Risk assessmenT and treAtment In AustraliaN primary care  (VICTORION-ASCERTAIN: Implementation Study).

The VICTORION-ASCERTAIN: Implementation Study is a two-arm, multicentre, randomised, open-label study to evaluate the implementation and utility of a new model of care in participants with ASCVD or ASCVD-risk equivalents and elevated LDL-C using a primary care model.

General Practitioners are invited to participate in this study if

  • you have an interest in participating in this clinical trial; and
  • your medical records are currently being managed by MedicalDirector Software;
  • you are able to recruit 30 patients as described below.


Brief Description of participants sought:

This study will include male and female participants ≥18 years of age with a history of ASCVD or ASCVD-risk equivalents who have elevated LDL-C (≥1.8 mmol/L).


Geographic location: Australia-wide, a total of approximately 600 participants will be included in the study across approximately 20 practices. 

If you are interested in participating or if you have any questions please email:

Primary email address: raeda.mustafa@monash.edu
Secondary email address: ascertain.study@monash.edu

ClinicalTrials.gov ID NCT05834673